| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1570-9639(02)00547-2 |
| P698 | PubMed publication ID | 12637008 |
| P50 | author | Barbara Seliger | Q88457780 |
| P2093 | author name string | Rudolf Lichtenfels | |
| Walburgis Brenner | |||
| Sebastian Melchior | |||
| Derek Atkins | |||
| Roland Kellner | |||
| Joachim Beck | |||
| Angelika Ackermann | |||
| Jürgen Bukur | |||
| P2860 | cites work | The level of manganese superoxide dismutase content is an independent prognostic factor for glioblastoma. Biological mechanisms and clinical implications | Q36622637 |
| Targeting of tumor associated antigens in renal cell carcinoma using proteome-based analysis and their clinical significance | Q40685088 | ||
| Growth factors and renal cancer: characterization and therapeutic implications | Q41442996 | ||
| Neural markers in carcinoma of the lung | Q41854869 | ||
| An alternative open reading frame of the human macrophage colony-stimulating factor gene is independently translated and codes for an antigenic peptide of 14 amino acids recognized by tumor-infiltrating CD8 T lymphocytes | Q42058413 | ||
| Differential expression of the subunits of the glucose-6-phosphatase system in the clear cell type of human renal cell carcinoma - no evidence for an overexpression of protein kinase B. | Q43588838 | ||
| Tumour-related enzyme alterations in the clear cell type of human renal cell carcinoma identified by two-dimensional gel electrophoresis | Q43808649 | ||
| Distinct behavior of mutant triosephosphate isomerase in hemolysate and in isolated form: molecular basis of enzyme deficiency | Q48719122 | ||
| Transcriptional inhibition of manganese superoxide dismutase (SOD2) gene expression by DNA methylation of the 5' CpG island. | Q53447694 | ||
| Integrating cancer genomics and proteomics in the post-genome era. | Q55473800 | ||
| Immunogold analysis of antioxidant enzymes in human renal cell carcinoma | Q57635288 | ||
| Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics | Q69578343 | ||
| Immunohistochemical markers of small cell carcinoma and related neuroendocrine tumours of the lung | Q69814691 | ||
| Morphological classification of renal cancer | Q71721263 | ||
| Chromogranin A gene expression in non-small cell lung carcinomas | Q77924460 | ||
| A new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcription | Q22010943 | ||
| The structure of human mitochondrial manganese superoxide dismutase reveals a novel tetrameric interface of two 4-helix bundles | Q27642140 | ||
| The ubiquitin system | Q27860803 | ||
| Renal cell carcinoma and normal kidney protein expression | Q28238205 | ||
| Biochemical identification of a mutated human melanoma antigen recognized by CD4(+) T cells | Q30442808 | ||
| Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen | Q30634368 | ||
| Mapping and expression pattern analysis of key components of the major histocompatibility complex class I antigen processing and presentation pathway in a representative human renal cell carcinoma cell line | Q30682199 | ||
| Role of accurate mass measurement (+/- 10 ppm) in protein identification strategies employing MS or MS/MS and database searching. | Q30744805 | ||
| Heat shock protein expression and anti-heat shock protein reactivity in renal cell carcinoma | Q31050911 | ||
| Superoxide dismutases | Q34008447 | ||
| Amyotrophic lateral sclerosis: a proposed mechanism | Q34066549 | ||
| Rapid mass spectrometric peptide sequencing and mass matching for characterization of human melanoma proteins isolated by two-dimensional PAGE. | Q34288141 | ||
| Proteomic-based approach for the identification of tumor markers associated with hepatocellular carcinoma | Q34493374 | ||
| A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma | Q36366872 | ||
| P433 | issue | 1-2 | |
| P921 | main subject | renal cell carcinoma | Q1164529 |
| P304 | page(s) | 21-31 | |
| P577 | publication date | 2003-03-01 | |
| P1433 | published in | Biochimica et Biophysica Acta | Q864239 |
| P1476 | title | Identification of metabolic enzymes in renal cell carcinoma utilizing PROTEOMEX analyses | |
| P478 | volume | 1646 |
| Q39651348 | A proteomic approach based on multiple parallel separation for the unambiguous identification of an antibody cognate antigen |
| Q35680148 | An Optimized Fluorescence-Based Bidimensional Immunoproteomic Approach for Accurate Screening of Autoantibodies |
| Q42784910 | Application of immunoproteomics to leptospirosis: towards clinical diagnostics and vaccine discovery |
| Q45859114 | Cancer immunomics and application of 'omics' for cancer management |
| Q37029097 | Candidate biomarkers in renal cell carcinoma |
| Q33411373 | Combined analysis of transcriptome and proteome data as a tool for the identification of candidate biomarkers in renal cell carcinoma |
| Q36227969 | Current progress in proteomic study of hepatitis C virus-related human hepatocellular carcinoma |
| Q40469914 | Cytotoxic and antiangiogenic activity of AW464 (NSC 706704), a novel thioredoxin inhibitor: an in vitro study. |
| Q38281782 | Dendritic cell-based vaccine research against cancer. |
| Q54474404 | Detection of autoantibodies against cyclophilin A and triosephosphate isomerase in sera from breast cancer patients by proteomic analysis. |
| Q30316645 | Distinct von Hippel-Lindau gene and hypoxia-regulated alterations in gene and protein expression patterns of renal cell carcinoma and their effects on metabolism |
| Q37415914 | Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma |
| Q33481705 | Identification of IMPDH2 as a tumor-associated antigen in colorectal cancer using immunoproteomics analysis |
| Q38326320 | Identification of fatty acid binding proteins as markers associated with the initiation and/or progression of renal cell carcinoma |
| Q42832158 | Influence of Ki-ras-driven oncogenic transformation on the protein network of murine fibroblasts |
| Q36920156 | Key clinical issues in renal cancer: a challenge for proteomics |
| Q38782056 | Natural Antibodies to Tumor-Associated Antigens |
| Q39236143 | Preventive cancer stem cell-based vaccination reduces liver metastasis development in a rat colon carcinoma syngeneic model |
| Q35170389 | Protein Microarray Signature of Autoantibody Biomarkers for the Early Detection of Breast Cancer |
| Q33229114 | Proteome analysis of human lung squamous carcinoma |
| Q33432732 | Proteome serological determination of tumor-associated antigens in melanoma |
| Q33519571 | Proteome-based analysis of serologically defined tumor-associated antigens in cutaneous lymphoma |
| Q33246457 | Proteomic analysis of autoantibodies in patients with hepatocellular carcinoma |
| Q36184802 | Proteomic analysis of renal diseases: unraveling the pathophysiology and biomarker discovery |
| Q39642376 | Proteomic and PROTEOMEX profiling of mammary cancer progression in a HER-2/neu oncogene-driven animal model system. |
| Q40165870 | Proteomics-based identification of HSP60 as a tumor-associated antigen in colorectal cancer. |
| Q31121927 | Proteomics: a novel tool to unravel the patho-physiology of uraemia |
| Q36019455 | Renal and urinary proteomics: current applications and challenges |
| Q80534129 | Significance of heat shock protein-27 expression in patients with renal cell carcinoma |
| Q30319002 | Systematic comparative protein expression profiling of clear cell renal cell carcinoma: a pilot study based on the separation of tissue specimens by two-dimensional gel electrophoresis |
| Q52367069 | The Immunome of Colon Cancer: Functional In Silico Analysis of Antigenic Proteins Deduced from IgG Microarray Profiling. |
Search more.